“Chilmark Research had the privilege and honor to present and moderate a session at the AHRQ’09 event here in Washington DC yesterday. Title of the session was PHRs: What Are They Good For? Along with Chilmark Research, we had Kim Slocum of KDS, James Hereford of Group Health and Ted Eytan of Kaiser-Permanente, each giving their own perspectives on the topic.”
Article
John Moore, Chilmark Research, 15 September 2009
